Docusign (NASDAQ:DOCU) Insider Robert Chatwani Sells 1,683 Shares

Docusign Inc. (NASDAQ:DOCUGet Free Report) insider Robert Chatwani sold 1,683 shares of the stock in a transaction on Monday, December 15th. The stock was sold at an average price of $70.87, for a total transaction of $119,274.21. Following the sale, the insider directly owned 68,496 shares in the company, valued at $4,854,311.52. This trade represents a 2.40% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link.

Robert Chatwani also recently made the following trade(s):

  • On Wednesday, December 17th, Robert Chatwani sold 13,818 shares of Docusign stock. The shares were sold at an average price of $68.33, for a total transaction of $944,183.94.
  • On Thursday, December 11th, Robert Chatwani sold 983 shares of Docusign stock. The stock was sold at an average price of $68.62, for a total transaction of $67,453.46.

Docusign Stock Up 0.3%

Shares of DOCU stock traded up $0.17 during mid-day trading on Thursday, hitting $67.96. 415,163 shares of the stock were exchanged, compared to its average volume of 2,749,383. Docusign Inc. has a 52-week low of $63.41 and a 52-week high of $99.30. The company has a market cap of $13.61 billion, a PE ratio of 47.24, a price-to-earnings-growth ratio of 3.39 and a beta of 0.98. The firm has a fifty day moving average of $68.97 and a 200 day moving average of $74.21.

Analyst Upgrades and Downgrades

Several analysts have commented on DOCU shares. Royal Bank Of Canada reissued a “sector perform” rating and issued a $95.00 price objective on shares of Docusign in a report on Friday, December 5th. Argus reissued a “hold” rating on shares of Docusign in a report on Monday, September 8th. Robert W. Baird decreased their price objective on shares of Docusign from $90.00 to $75.00 and set a “neutral” rating on the stock in a report on Friday, December 5th. JMP Securities reiterated a “market outperform” rating and issued a $124.00 target price on shares of Docusign in a research report on Friday, October 3rd. Finally, Zacks Research lowered Docusign from a “strong-buy” rating to a “hold” rating in a research note on Monday, November 24th. Six equities research analysts have rated the stock with a Buy rating and sixteen have given a Hold rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $86.80.

Check Out Our Latest Research Report on DOCU

Hedge Funds Weigh In On Docusign

A number of institutional investors and hedge funds have recently bought and sold shares of the business. IFP Advisors Inc grew its stake in Docusign by 31.9% during the 3rd quarter. IFP Advisors Inc now owns 1,955 shares of the company’s stock valued at $145,000 after acquiring an additional 473 shares in the last quarter. Strategic Advocates LLC acquired a new position in shares of Docusign during the 3rd quarter worth approximately $50,000. CIBC Bancorp USA Inc. purchased a new stake in shares of Docusign in the third quarter valued at approximately $522,000. Centaurus Financial Inc. increased its holdings in shares of Docusign by 3.4% in the third quarter. Centaurus Financial Inc. now owns 5,582 shares of the company’s stock valued at $402,000 after purchasing an additional 184 shares during the last quarter. Finally, Coldstream Capital Management Inc. lifted its position in Docusign by 21.1% during the third quarter. Coldstream Capital Management Inc. now owns 4,147 shares of the company’s stock worth $299,000 after buying an additional 723 shares in the last quarter. 77.64% of the stock is currently owned by institutional investors and hedge funds.

About Docusign

(Get Free Report)

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.

Read More

Insider Buying and Selling by Quarter for Docusign (NASDAQ:DOCU)

Receive News & Ratings for Docusign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Docusign and related companies with MarketBeat.com's FREE daily email newsletter.